J. McDermott

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
James J. Mcdermott, James Mcdermott, James J Mcdermott, J. Mcdermott, Jim Mcdermott
Publication record
20 papers · 629 citations · H-index 9

PAPERS

Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy.
202412 citationsauthor #12
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure.
20242 citationsauthor #13
TOTAL AND CAUSE-SPECIFIC HEALTHCARE COSTS FOLLOWING HOSPITALIZATION FOR HEART FAILURE WITH REDUCED VS MILDLY REDUCED/PRESERVED EJECTION FRACTION
20240 citationsauthor #10
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
202380 citationsauthor #16
Medical Therapy Before, During, and After Hospitalization in Medicare Beneficiaries with Heart Failure and Diabetes: The Get With The Guidelines - Heart Failure Registry.
20238 citationsauthor #13
Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial.
202332 citationsauthor #11
Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry.
202389 citationsauthor #13
Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
2022154 citationsauthor #10
Pragmatic Trial of Messaging to Providers About Treatment of Acute Heart Failure: The PROMPT-AHF Trial.
20223 citationsauthor #10
Abstract 14215: Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors
20210 citationsauthor #11
Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
2021161 citationsauthor #12
Abstract 14383: Medical Therapy Before, During, and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: The Get With the Guidelines - Heart Failure Registry
20210 citationsauthor #12
CLINICAL PROFILES, MEDICAL THERAPIES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HF ACROSS THE SPECTRUM OF KIDNEY FUNCTION: THE GWTG-HF REGISTRY
20211 citationsauthor #12
Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors among Medicare Beneficiaries Hospitalized for Heart Failure.
20216 citationsauthor #12
Abstract 14304: Incident Dialysis and Acute Kidney Injury Among Medicare Beneficiaries After Hospitalization for Heart Failure in the US
20210 citationsauthor #12
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.
202043 citationsauthor #11
Abstract 17027: Generalizability of the US FDA Label for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in the GWTG-HF Registry
20200 citationsauthor #11
5 Oxidative Stress and Antioxidants : Preterm Birth and Preterm Infants
20170 citationsauthor #3
Oxidative Stress and Antioxidants: Preterm Birth and Preterm Infants
201213 citationsauthor #3
The excretion of 5‐oxoproline in urine, as an index of glycine status, during normal pregnancy
198928 citationsauthor #2

TIMELINE

1989 28 citations

2012 13 citations

2017 0 citations

2020 43 citations

2021 168 citations

2022 157 citations

2023 209 citations

2024 14 citations

J. McDermott

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT